Skip to content

Pre-admission Statin Therapy and Clinical Outcome in Aneurysmal Subarachnoid Hemorrhage: A Multicenter Retrospective Cohort Study

Pre-admission Statin Therapy and Clinical Outcome in Aneurysmal Subarachnoid Hemorrhage: A Multicenter Retrospective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300079305
Enrollment
Unknown
Registered
2023-12-29
Start date
2023-02-28
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aneurysmal Subarachnoid Hemorrhage

Interventions

pre-admission statin group (statin group):None

Sponsors

Tianjin Medical University General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1) both male and female adults aged over 18 years; 2) present with acute SAH diagnosed by computed tomography (CT); 3) confirmation of an intracranial aneurysm by digital subtraction angiography, CT angiography, or magnetic resonance angiography); 4) admitted within 72 hours following SAH; 5) Surgical options for aneurysms (clipping or coiling) initiated within 48 hours of admission; 6) absence of other significant intracranial diseases, including but not limited to pre-admission diagnoses of Moyamoya disease, multiple sclerosis, dementia, epilepsy disorder, cerebral infarction, encephalitis, or malignant brain tumor) ; and 7) availability of complete clinical data.

Exclusion criteria

Exclusion criteria: 1) SAH caused by trauma and other non-aneurysm rupture; 2) a history of neurological functional score-affecting diseases; 3) concurrent serious systemic diseases including systemic infection, multiple organ failure, and gastrointestinal bleeding; 4) insufficient or indistinct clinical data; 5) recent use of glucocorticoids; 6) concurrent liver dysfunction; and 7) extremely prolonged or abbreviated hospital stays (80 days).

Design outcomes

Primary

MeasureTime frame
Modified Rankin Scale (mRS) Score;

Secondary

MeasureTime frame
intraventricular hemorrhage rate;hydrocephalus rate;recurrent cerebral hemorrhage rate;external ventricular drainage rate;

Countries

China

Contacts

Public ContactRongcai Jiang

Tianjin Medical University General Hospital

jiang116216@163.com+86 188 9568 1658

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026